The AAO is largely supportive of the bill, S. 959, but calls for exemption from provisions that require specific patient designation for biological products and marketed drugs. The Academy argues there is no evidence linking safe repackaging processes with the use of a patient’s name when labeling a drug.
More Articles on Ophthalmology:
Dr. Judy Meyers Joins Ophthalmology Associates in Fort Worth
ARVO Names Dr. Justine Smith President, Dr. William Mieler President-Elect
8 Recent Eye Surgery Center Openings, Mergers & Acquisitions
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
